News Conference News THT 2025 Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity Todd Neale February 12, 2025
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Conference News ACC 2024 STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed L.A. McKeown April 06, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2023 Shelley Wood November 30, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2023 Caitlin E. Cox September 04, 2023
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022
News Daily News Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19 Michael O'Riordan July 20, 2022
News Daily News Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick Michael O'Riordan January 20, 2022
News Daily News Sex-Based Differences for Heart Failure Risk Need More Attention, Research Yael L. Maxwell February 28, 2019
Presentation TCT 2018 Selective CRP Apheresis as a New Treatment Option in Acute Myocardial Infarction: First Results of the CAMI1 Study Presenter: Ulrich P. Jorde, John M. Lasala, Christoph Garlichs September 21, 2018
News Daily News Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations Todd Neale June 04, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017